(Q39341881)

English

Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine

scientific article published on January 2007

In more languages
default for all languages
No label defined

No description defined

Statements

Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit